FDA Application
-
NDC Search Results on Active Ingredient: codeine
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
CODEINE PHOSPHATE; ACETAMINOPHEN | 50383-340-17 | Akorn | ANDA040119 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE | 50383-804-04 | Akorn | ANDA040151 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE | 50383-804-16 | Akorn | ANDA040151 | HUMAN PRESCRIPTION DRUG | ANDA |
PROMETHAZINE HYDROCHLORIDE; CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE | 50383-805-04 | Akorn | ANDA040674 | HUMAN PRESCRIPTION DRUG | ANDA |
PROMETHAZINE HYDROCHLORIDE; CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE | 50383-805-16 | Akorn | ANDA040674 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE | 50436-1029-1 | Unit Dose Services | ANDA040650 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; GUAIFENESIN | 50436-2520-1 | Unit Dose Services | part341 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
ACETAMINOPHEN; CODEINE PHOSPHATE | 50436-3227-1 | Unit Dose Services | ANDA040779 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 50436-3227-2 | Unit Dose Services | ANDA040779 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 50436-3227-7 | Unit Dose Services | ANDA040779 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 50436-3227-9 | Unit Dose Services | ANDA040779 | HUMAN PRESCRIPTION DRUG | ANDA |
BROMPHENIRAMINE MALEATE; CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE | 50991-723-15 | Poly Pharmaceuticals, Inc. | HUMAN OTC DRUG | unapproved drug other | |
BROMPHENIRAMINE MALEATE; CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE | 50991-723-16 | Poly Pharmaceuticals, Inc. | HUMAN OTC DRUG | unapproved drug other | |
ACETAMINOPHEN; CODEINE PHOSPHATE | 51655-802-53 | Northwind Pharmaceuticals, LLC | ANDA040779 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 51655-802-54 | Northwind Pharmaceuticals, LLC | ANDA040779 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 51655-808-52 | Northwind Pharmaceuticals | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 51655-808-53 | Northwind Pharmaceuticals | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 51655-808-54 | Northwind Pharmaceuticals | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 51655-808-87 | Northwind Pharmaceuticals | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 51655-910-54 | Northwind Pharmaceuticals, LLC | ANDA211610 | HUMAN PRESCRIPTION DRUG | ANDA |
BUTALBITAL; CODEINE PHOSPHATE; CAFFEINE; ACETAMINOPHEN | 51991-073-01 | Breckenridge Pharmaceutical, Inc. | ANDA076560 | HUMAN PRESCRIPTION DRUG | ANDA |
BUTALBITAL; CAFFEINE; ASPIRIN; CODEINE PHOSPHATE | 51991-074-01 | Breckenridge Pharmaceutical, Inc. | ANDA075231 | HUMAN PRESCRIPTION DRUG | ANDA |
BUTALBITAL; CAFFEINE; ASPIRIN; CODEINE PHOSPHATE | 51991-074-05 | Breckenridge Pharmaceutical, Inc. | ANDA075231 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; BUTALBITAL; ACETAMINOPHEN; CAFFEINE | 52544-082-01 | Actavis Pharma, Inc. | ANDA076560 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 52959-003-00 | H.J. Harkins Company, Inc. | ANDA089805 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 52959-003-02 | H.J. Harkins Company, Inc. | ANDA089805 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 52959-003-04 | H.J. Harkins Company, Inc. | ANDA089805 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 52959-003-06 | H.J. Harkins Company, Inc. | ANDA089805 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 52959-003-10 | H.J. Harkins Company, Inc. | ANDA089805 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 52959-003-12 | H.J. Harkins Company, Inc. | ANDA089805 | HUMAN PRESCRIPTION DRUG | ANDA |
1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-180 | 181-210 | 211-240 | 241-270 | 271-300 |
301-330 | 331-360 | 361-390 | 391-420 | 421-450 | 451-480 | 481-510 | 511-540 | 541-570 | 571-600 |
601-630 | 631-660 | 661-690 | 691-720 | 721-750 | 751-764 |
-